| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN805CH2000 | 2000-09-26 | ||
| PCT/US2001/029896WO2002026737A1 (en) | 2000-09-26 | 2001-09-25 | Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
| Publication Number | Publication Date |
|---|---|
| HUP0301161A2 HUP0301161A2 (en) | 2003-11-28 |
| HUP0301161A3true HUP0301161A3 (en) | 2005-04-28 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0301161AHUP0301161A3 (en) | 2000-09-26 | 2001-09-25 | Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleate and process for their preparation |
| Country | Link |
|---|---|
| EP (1) | EP1322647A1 (en) |
| JP (1) | JP2004509961A (en) |
| AU (1) | AU9123201A (en) |
| BR (1) | BR0114196A (en) |
| CA (1) | CA2426117A1 (en) |
| CZ (1) | CZ2003864A3 (en) |
| HU (1) | HUP0301161A3 (en) |
| IL (1) | IL155036A0 (en) |
| MX (1) | MXPA03002580A (en) |
| NO (1) | NO324968B1 (en) |
| NZ (1) | NZ525498A (en) |
| PL (1) | PL360661A1 (en) |
| SK (1) | SK3752003A3 (en) |
| WO (1) | WO2002026737A1 (en) |
| ZA (1) | ZA200303223B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| US6664278B2 (en) | 1997-12-16 | 2003-12-16 | Smithkline Beecham P.L.C. | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| GB9726563D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| KR100744360B1 (en) | 1999-04-23 | 2007-07-30 | 스미스클라인비이참피이엘시이 | Polymorph of 5- [4- [2- (N-methyl-N- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione maleate |
| AP1495A (en) | 1999-04-23 | 2005-11-30 | Smithkline Beecham Plc | Thiazolidinedione derivative and its use as antidiabetic. |
| US20040248945A1 (en) | 1999-04-23 | 2004-12-09 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
| US7041691B1 (en) | 1999-06-30 | 2006-05-09 | Amgen Inc. | Compounds for the modulation of PPARγ activity |
| US20030171399A1 (en) | 2000-06-28 | 2003-09-11 | Tularik Inc. | Quinolinyl and benzothiazolyl modulators |
| WO2004062667A1 (en)* | 2003-01-08 | 2004-07-29 | Dr. Reddy's Laboratories Limited | Amorphous form of rosiglitazone maleate and process for preparation thereof |
| GB0307259D0 (en)* | 2003-03-28 | 2003-05-07 | Glaxo Group Ltd | Process |
| EP1468997A3 (en)* | 2003-04-18 | 2004-11-03 | CHEMI S.p.A. | Polymorphous forms of rosiglitazone maleate |
| GB2405403A (en)* | 2003-08-29 | 2005-03-02 | Cipla Ltd | Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base |
| UA83504C2 (en) | 2003-09-04 | 2008-07-25 | Селджин Корпорейшн | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| US7223761B2 (en) | 2003-10-03 | 2007-05-29 | Amgen Inc. | Salts and polymorphs of a potent antidiabetic compound |
| AR047541A1 (en)* | 2004-02-13 | 2006-01-25 | Sandoz Ag | PHOSPHATE OF 5 - [[4- [2-METHYL-2-PYRIDINYL-AMINO-ETOXI] PHENYL] METHYL] -2,4 THYZOLIDINADION (ROSIGLITAZONE) AND ITS POLYMORPHIC FORMS |
| EP1753759A2 (en)* | 2004-03-31 | 2007-02-21 | Sandoz AG | Novel co-precipitate of amorphous rosiglitazone |
| EP1757603A4 (en)* | 2004-05-11 | 2008-06-25 | Santen Pharmaceutical Co Ltd | Therapeutic agent for keratoconjunctiva disorder |
| JP2005350451A (en)* | 2004-05-11 | 2005-12-22 | Santen Pharmaceut Co Ltd | Agent for treating keratoconjunctival trouble |
| CZ2004844A3 (en)* | 2004-07-27 | 2006-03-15 | Zentiva, A. S | Salt of oxalic acid with 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, process for its preparation and its use |
| ITMI20041537A1 (en)* | 2004-07-28 | 2004-10-28 | Chemi Spa | NEW POLYMORPHIC SHAPE OF EVIL ROSIGLITAZONE |
| CZ298424B6 (en)* | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Crystallization process of rosiglitazone and derivatives thereof from mixed solutions |
| EP2184055A1 (en) | 2008-11-07 | 2010-05-12 | LEK Pharmaceuticals d.d. | Process for preparing solid dosage forms of rosiglitazone maleate |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0842925A1 (en)* | 1987-09-04 | 1998-05-20 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
| GB9218830D0 (en)* | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| WO1997027191A1 (en)* | 1996-06-19 | 1997-07-31 | Dr. Reddy's Research Foundation | Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation |
| EP0923580A1 (en)* | 1996-07-26 | 1999-06-23 | Dr. Reddy's Research Foundation | Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof |
| GB9726566D0 (en)* | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| KR100744360B1 (en)* | 1999-04-23 | 2007-07-30 | 스미스클라인비이참피이엘시이 | Polymorph of 5- [4- [2- (N-methyl-N- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione maleate |
| AP1495A (en)* | 1999-04-23 | 2005-11-30 | Smithkline Beecham Plc | Thiazolidinedione derivative and its use as antidiabetic. |
| Publication number | Publication date |
|---|---|
| BR0114196A (en) | 2003-07-22 |
| PL360661A1 (en) | 2004-09-20 |
| HUP0301161A2 (en) | 2003-11-28 |
| CA2426117A1 (en) | 2002-04-04 |
| NO20031356L (en) | 2003-05-26 |
| WO2002026737A1 (en) | 2002-04-04 |
| JP2004509961A (en) | 2004-04-02 |
| AU9123201A (en) | 2002-04-08 |
| CZ2003864A3 (en) | 2004-01-14 |
| ZA200303223B (en) | 2004-07-26 |
| IL155036A0 (en) | 2003-10-31 |
| NO20031356D0 (en) | 2003-03-25 |
| WO2002026737A8 (en) | 2003-11-06 |
| MXPA03002580A (en) | 2003-10-15 |
| NO324968B1 (en) | 2008-01-14 |
| NZ525498A (en) | 2004-11-26 |
| EP1322647A1 (en) | 2003-07-02 |
| SK3752003A3 (en) | 2005-03-04 |
| Publication | Publication Date | Title |
|---|---|---|
| HUP0301161A3 (en) | Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleate and process for their preparation | |
| DZ3316A1 (en) | Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione | |
| IL146111A0 (en) | 5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt | |
| HUP0100509A3 (en) | 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical, process for its preparation and its pharmaceutical use | |
| IL136381A (en) | Hydrate of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino) ethoxy] benzyl] thiazolidine-2,4-dione maleic acid salt, its preparation and pharmaceutical compositions comprising it | |
| HUP0300938A3 (en) | The hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione | |
| IL188116A0 (en) | Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione | |
| AU6255001A (en) | 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical | |
| HK1057209A (en) | Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benz yl]thiazolidine-2,4-dione maleic acid salt and process for their preparation | |
| HK1059259A (en) | Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione | |
| SI1265893T1 (en) | Hydrochloride salts of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione | |
| SI1173435T1 (en) | Polymorph of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione maleic acid salt | |
| HK1032905A (en) | 5-[4-[2-(n-methyl-n-(2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical | |
| HK1028191A (en) | Composition comprising 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazo lidine-2,4-dione | |
| HK1032955A (en) | Hydrate of 5-[4-[2- (n-methyl-n- (2-pyridil)amino) ethoxy]benzyl] thiazolidine-2, 4-dione maleic acid salt |
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees | ||
| FD9A | Lapse of provisional protection due to non-payment of fees |